Evidence map›Paper›PMID 39937697›Full record

ArticleHealth promotion and chronic disease prevention in Canada : research, policy and practice2025

A conceptual framework for the public health monitoring of substance-related harms.

Heather M Orpana, Aganeta Enns, Megan Striha, Diana George, Abban Yusuf, Stephanie L Hughes, Le Li, Laura H Thompson

Abstract read
In one paragraph

Article in Health promotion and chronic disease prevention in Canada : research, policy and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Heather M OrpanaCentre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Aganeta EnnsCentre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Megan StrihaCentre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Diana GeorgeCentre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Abban YusufCentre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Stephanie L HughesCentre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Le LiCentre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Laura H ThompsonCentre for Surveillance and Applied Research, Health Promotion and Chronic Disease Prevention Branch, Public Health Agency of Canada, Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Executive summary: The drug toxicity crisis in Canada and elsewhere has increased the need for timely and relevant data to inform policies and programs aimed at mitigating substance-related harms. While a number of monitoring systems addressing specific components of substance use and related harms in Canada exist, they are not guided by an overarching conceptual framework. This evidence-informed policy brief describes the development of a conceptual framework for the public health monitoring of substance-related harms. The resulting framework includes four primary topic areas (risk and protective factors, substance use, health supporting systems and substance-related harms and benefits) four cross-cutting topic areas (life course, equity, substance use stigma and mental and physical health and illness) and two overarching considerations (respectful use of data and engagement). This framework can be used to organize existing activities and to identify data and monitoring gaps for further development.

Indexed as

Public HealthSubstance-Related DisordersCanadaHealth PolicyHumansRisk FactorsSocial Stigmamonitoringopioidsoverdosesubstance-related harmssubstance usesurveillance

Identifiers

PMID39937697
PMCPMC11987590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.